A Win For Tiziana Life Sciences PLC

Thu, Mar 10, 2022 at 05:30 PM
A Win For Tiziana Life Sciences PLC

Tiziana Life Sciences PLC (TLSA:NASDAQ) shot up at $0.96, a gain of 30.4%. The stock got featured on our News Catalysts scanner on Thu, Mar 10, 2022 at 07:41 AM in the 'BIOTECH' category. From Thu, Feb 24, 2022, the stock recorded 55.56% Up Days and 70.00% Green Days

About Tiziana Life Sciences PLC (TLSA:NASDAQ)

Tiziana Life Sciences PLC is involved in the business of developing novel therapeutics for cancer with a focus on late-stage growth and complementary diagnostic tools, with the capability of predicting disease aggressiveness and prognosis in breast cancer patients. The group also has interests, beyond pure oncology, in the discovery and development of monoclonal antibody-based biologics used to benefit patients with inflammatory and auto-immune disorders. The company has a single reporting segment, The Research, and Development of Biotechnological and Pharmaceutical Products. Its lead compound, milciclib (TZLS-201), is a molecule which blocks the action of specific enzymes involved in cell division as well as a number of other protein kinases.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.